Startups
Surf Bio
Developed polymer-based formulations that stabilize antibodies and other biologics at very high concentrations, aiming to replace lengthy intravenous infusions with rapid subcutaneous injections. Its SnapShot platform supported drug-delivery partnerships. Halozyme acquired the company in December 2025 and announced the transaction in January 2026.
Founded 2021